 | • レポートコード：MRC2Q12-16775 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、止血用粉末＆止血剤のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 止血用粉末＆止血剤のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 止血用粉末＆止血剤の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 止血用粉末＆止血剤のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの止血用粉末＆止血剤の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の止血用粉末＆止血剤の売上および2028年までの予測に焦点を当てています。 止血用粉末＆止血剤のグローバル主要企業には、BD、Medline Industries、Baxter、Pfizer、Zimmer Biomet、McKesson、Integra Life Sciences、Medtronic、CryoLife、CSL Behring、Ethicon、B Braun Melsungen、Gelita Medical、Smith & Nephew、Teleflexなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 止血用粉末＆止血剤市場は、タイプとアプリケーションによって区分されます。世界の止血用粉末＆止血剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 微小繊維状コラーゲン、キトサン 【アプリケーション別セグメント】 家庭用、診療所、病院 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 止血用粉末＆止血剤製品概要 - タイプ別市場（微小繊維状コラーゲン、キトサン） - アプリケーション別市場（家庭用、診療所、病院） - 調査の目的 ・エグゼクティブサマリー - 世界の止血用粉末＆止血剤販売量予測2017-2028 - 世界の止血用粉末＆止血剤売上予測2017-2028 - 止血用粉末＆止血剤の地域別販売量 - 止血用粉末＆止血剤の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別止血用粉末＆止血剤販売量 - 主要メーカー別止血用粉末＆止血剤売上 - 主要メーカー別止血用粉末＆止血剤価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（微小繊維状コラーゲン、キトサン） - 止血用粉末＆止血剤のタイプ別販売量 - 止血用粉末＆止血剤のタイプ別売上 - 止血用粉末＆止血剤のタイプ別価格 ・アプリケーション別市場規模（家庭用、診療所、病院） - 止血用粉末＆止血剤のアプリケーション別販売量 - 止血用粉末＆止血剤のアプリケーション別売上 - 止血用粉末＆止血剤のアプリケーション別価格 ・北米市場 - 北米の止血用粉末＆止血剤市場規模（タイプ別、アプリケーション別） - 主要国別の止血用粉末＆止血剤市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの止血用粉末＆止血剤市場規模（タイプ別、アプリケーション別） - 主要国別の止血用粉末＆止血剤市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の止血用粉末＆止血剤市場規模（タイプ別、アプリケーション別） - 主要国別の止血用粉末＆止血剤市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の止血用粉末＆止血剤市場規模（タイプ別、アプリケーション別） - 主要国別の止血用粉末＆止血剤市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの止血用粉末＆止血剤市場規模（タイプ別、アプリケーション別） - 主要国別の止血用粉末＆止血剤市場規模（トルコ、サウジアラビア） ・企業情報 BD、Medline Industries、Baxter、Pfizer、Zimmer Biomet、McKesson、Integra Life Sciences、Medtronic、CryoLife、CSL Behring、Ethicon、B Braun Melsungen、Gelita Medical、Smith & Nephew、Teleflex ・産業チェーン及び販売チャネル分析 - 止血用粉末＆止血剤の産業チェーン分析 - 止血用粉末＆止血剤の原材料 - 止血用粉末＆止血剤の生産プロセス - 止血用粉末＆止血剤の販売及びマーケティング - 止血用粉末＆止血剤の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 止血用粉末＆止血剤の産業動向 - 止血用粉末＆止血剤のマーケットドライバー - 止血用粉末＆止血剤の課題 - 止血用粉末＆止血剤の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Hemostatic Powders and Hemostatic Agents estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Hemostatic Powders and Hemostatic Agents is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Hemostatic Powders and Hemostatic Agents is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Hemostatic Powders and Hemostatic Agents is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Hemostatic Powders and Hemostatic Agents include BD, Medline Industries, Baxter, Pfizer, Zimmer Biomet, McKesson, Integra Life Sciences, Medtronic and CryoLife, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Hemostatic Powders and Hemostatic Agents companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Hemostatic Powders and Hemostatic Agents market. Further, it explains the major drivers and regional dynamics of the global Hemostatic Powders and Hemostatic Agents market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
BD
Medline Industries
Baxter
Pfizer
Zimmer Biomet
McKesson
Integra Life Sciences
Medtronic
CryoLife
CSL Behring
Ethicon
B Braun Melsungen
Gelita Medical
Smith & Nephew
Teleflex
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Hemostatic Powders and Hemostatic Agents Segment by Type
Microfibrous Collagen
Chitosan
Hemostatic Powders and Hemostatic Agents Segment by Application
Home
Clinic
Hospital
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Hemostatic Powders and Hemostatic Agents market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Hemostatic Powders and Hemostatic Agents market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Hemostatic Powders and Hemostatic Agents, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Hemostatic Powders and Hemostatic Agents, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hemostatic Powders and Hemostatic Agents revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Hemostatic Powders and Hemostatic Agents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Hemostatic Powders and Hemostatic Agents revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including BD, Medline Industries, Baxter, Pfizer, Zimmer Biomet, McKesson, Integra Life Sciences, Medtronic and CryoLife, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Hemostatic Powders and Hemostatic Agents in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hemostatic Powders and Hemostatic Agents companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hemostatic Powders and Hemostatic Agents revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemostatic Powders and Hemostatic Agents Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Microfibrous Collagen
1.2.3 Chitosan
1.3 Market by Application
1.3.1 Global Hemostatic Powders and Hemostatic Agents Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Home
1.3.3 Clinic
1.3.4 Hospital
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hemostatic Powders and Hemostatic Agents Market Perspective (2017-2028)
2.2 Hemostatic Powders and Hemostatic Agents Growth Trends by Region
2.2.1 Hemostatic Powders and Hemostatic Agents Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Hemostatic Powders and Hemostatic Agents Historic Market Size by Region (2017-2022)
2.2.3 Hemostatic Powders and Hemostatic Agents Forecasted Market Size by Region (2023-2028)
2.3 Hemostatic Powders and Hemostatic Agents Market Dynamics
2.3.1 Hemostatic Powders and Hemostatic Agents Industry Trends
2.3.2 Hemostatic Powders and Hemostatic Agents Market Drivers
2.3.3 Hemostatic Powders and Hemostatic Agents Market Challenges
2.3.4 Hemostatic Powders and Hemostatic Agents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hemostatic Powders and Hemostatic Agents Players by Revenue
3.1.1 Global Top Hemostatic Powders and Hemostatic Agents Players by Revenue (2017-2022)
3.1.2 Global Hemostatic Powders and Hemostatic Agents Revenue Market Share by Players (2017-2022)
3.2 Global Hemostatic Powders and Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hemostatic Powders and Hemostatic Agents Revenue
3.4 Global Hemostatic Powders and Hemostatic Agents Market Concentration Ratio
3.4.1 Global Hemostatic Powders and Hemostatic Agents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemostatic Powders and Hemostatic Agents Revenue in 2021
3.5 Hemostatic Powders and Hemostatic Agents Key Players Head office and Area Served
3.6 Key Players Hemostatic Powders and Hemostatic Agents Product Solution and Service
3.7 Date of Enter into Hemostatic Powders and Hemostatic Agents Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemostatic Powders and Hemostatic Agents Breakdown Data by Type
4.1 Global Hemostatic Powders and Hemostatic Agents Historic Market Size by Type (2017-2022)
4.2 Global Hemostatic Powders and Hemostatic Agents Forecasted Market Size by Type (2023-2028)
5 Hemostatic Powders and Hemostatic Agents Breakdown Data by Application
5.1 Global Hemostatic Powders and Hemostatic Agents Historic Market Size by Application (2017-2022)
5.2 Global Hemostatic Powders and Hemostatic Agents Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Hemostatic Powders and Hemostatic Agents Market Size (2017-2028)
6.2 North America Hemostatic Powders and Hemostatic Agents Market Size by Type
6.2.1 North America Hemostatic Powders and Hemostatic Agents Market Size by Type (2017-2022)
6.2.2 North America Hemostatic Powders and Hemostatic Agents Market Size by Type (2023-2028)
6.2.3 North America Hemostatic Powders and Hemostatic Agents Market Share by Type (2017-2028)
6.3 North America Hemostatic Powders and Hemostatic Agents Market Size by Application
6.3.1 North America Hemostatic Powders and Hemostatic Agents Market Size by Application (2017-2022)
6.3.2 North America Hemostatic Powders and Hemostatic Agents Market Size by Application (2023-2028)
6.3.3 North America Hemostatic Powders and Hemostatic Agents Market Share by Application (2017-2028)
6.4 North America Hemostatic Powders and Hemostatic Agents Market Size by Country
6.4.1 North America Hemostatic Powders and Hemostatic Agents Market Size by Country (2017-2022)
6.4.2 North America Hemostatic Powders and Hemostatic Agents Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Hemostatic Powders and Hemostatic Agents Market Size (2017-2028)
7.2 Europe Hemostatic Powders and Hemostatic Agents Market Size by Type
7.2.1 Europe Hemostatic Powders and Hemostatic Agents Market Size by Type (2017-2022)
7.2.2 Europe Hemostatic Powders and Hemostatic Agents Market Size by Type (2023-2028)
7.2.3 Europe Hemostatic Powders and Hemostatic Agents Market Share by Type (2017-2028)
7.3 Europe Hemostatic Powders and Hemostatic Agents Market Size by Application
7.3.1 Europe Hemostatic Powders and Hemostatic Agents Market Size by Application (2017-2022)
7.3.2 Europe Hemostatic Powders and Hemostatic Agents Market Size by Application (2023-2028)
7.3.3 Europe Hemostatic Powders and Hemostatic Agents Market Share by Application (2017-2028)
7.4 Europe Hemostatic Powders and Hemostatic Agents Market Size by Country
7.4.1 Europe Hemostatic Powders and Hemostatic Agents Market Size by Country (2017-2022)
7.4.2 Europe Hemostatic Powders and Hemostatic Agents Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Size (2017-2028)
8.2 Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Size by Type
8.2.1 Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Share by Type (2017-2028)
8.3 Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Size by Application
8.3.1 Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Share by Application (2017-2028)
8.4 Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Size by Region
8.4.1 Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hemostatic Powders and Hemostatic Agents Market Size (2017-2028)
9.2 Latin America Hemostatic Powders and Hemostatic Agents Market Size by Type
9.2.1 Latin America Hemostatic Powders and Hemostatic Agents Market Size by Type (2017-2022)
9.2.2 Latin America Hemostatic Powders and Hemostatic Agents Market Size by Type (2023-2028)
9.2.3 Latin America Hemostatic Powders and Hemostatic Agents Market Share by Type (2017-2028)
9.3 Latin America Hemostatic Powders and Hemostatic Agents Market Size by Application
9.3.1 Latin America Hemostatic Powders and Hemostatic Agents Market Size by Application (2017-2022)
9.3.2 Latin America Hemostatic Powders and Hemostatic Agents Market Size by Application (2023-2028)
9.3.3 Latin America Hemostatic Powders and Hemostatic Agents Market Share by Application (2017-2028)
9.4 Latin America Hemostatic Powders and Hemostatic Agents Market Size by Country
9.4.1 Latin America Hemostatic Powders and Hemostatic Agents Market Size by Country (2017-2022)
9.4.2 Latin America Hemostatic Powders and Hemostatic Agents Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Size (2017-2028)
10.2 Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Size by Type
10.2.1 Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Share by Type (2017-2028)
10.3 Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Size by Application
10.3.1 Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Share by Application (2017-2028)
10.4 Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Size by Country
10.4.1 Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Hemostatic Powders and Hemostatic Agents Introduction
11.1.4 BD Revenue in Hemostatic Powders and Hemostatic Agents Business (2017-2022)
11.1.5 BD Recent Developments
11.2 Medline Industries
11.2.1 Medline Industries Company Details
11.2.2 Medline Industries Business Overview
11.2.3 Medline Industries Hemostatic Powders and Hemostatic Agents Introduction
11.2.4 Medline Industries Revenue in Hemostatic Powders and Hemostatic Agents Business (2017-2022)
11.2.5 Medline Industries Recent Developments
11.3 Baxter
11.3.1 Baxter Company Details
11.3.2 Baxter Business Overview
11.3.3 Baxter Hemostatic Powders and Hemostatic Agents Introduction
11.3.4 Baxter Revenue in Hemostatic Powders and Hemostatic Agents Business (2017-2022)
11.3.5 Baxter Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Hemostatic Powders and Hemostatic Agents Introduction
11.4.4 Pfizer Revenue in Hemostatic Powders and Hemostatic Agents Business (2017-2022)
11.4.5 Pfizer Recent Developments
11.5 Zimmer Biomet
11.5.1 Zimmer Biomet Company Details
11.5.2 Zimmer Biomet Business Overview
11.5.3 Zimmer Biomet Hemostatic Powders and Hemostatic Agents Introduction
11.5.4 Zimmer Biomet Revenue in Hemostatic Powders and Hemostatic Agents Business (2017-2022)
11.5.5 Zimmer Biomet Recent Developments
11.6 McKesson
11.6.1 McKesson Company Details
11.6.2 McKesson Business Overview
11.6.3 McKesson Hemostatic Powders and Hemostatic Agents Introduction
11.6.4 McKesson Revenue in Hemostatic Powders and Hemostatic Agents Business (2017-2022)
11.6.5 McKesson Recent Developments
11.7 Integra Life Sciences
11.7.1 Integra Life Sciences Company Details
11.7.2 Integra Life Sciences Business Overview
11.7.3 Integra Life Sciences Hemostatic Powders and Hemostatic Agents Introduction
11.7.4 Integra Life Sciences Revenue in Hemostatic Powders and Hemostatic Agents Business (2017-2022)
11.7.5 Integra Life Sciences Recent Developments
11.8 Medtronic
11.8.1 Medtronic Company Details
11.8.2 Medtronic Business Overview
11.8.3 Medtronic Hemostatic Powders and Hemostatic Agents Introduction
11.8.4 Medtronic Revenue in Hemostatic Powders and Hemostatic Agents Business (2017-2022)
11.8.5 Medtronic Recent Developments
11.9 CryoLife
11.9.1 CryoLife Company Details
11.9.2 CryoLife Business Overview
11.9.3 CryoLife Hemostatic Powders and Hemostatic Agents Introduction
11.9.4 CryoLife Revenue in Hemostatic Powders and Hemostatic Agents Business (2017-2022)
11.9.5 CryoLife Recent Developments
11.10 CSL Behring
11.10.1 CSL Behring Company Details
11.10.2 CSL Behring Business Overview
11.10.3 CSL Behring Hemostatic Powders and Hemostatic Agents Introduction
11.10.4 CSL Behring Revenue in Hemostatic Powders and Hemostatic Agents Business (2017-2022)
11.10.5 CSL Behring Recent Developments
11.11 Ethicon
11.11.1 Ethicon Company Details
11.11.2 Ethicon Business Overview
11.11.3 Ethicon Hemostatic Powders and Hemostatic Agents Introduction
11.11.4 Ethicon Revenue in Hemostatic Powders and Hemostatic Agents Business (2017-2022)
11.11.5 Ethicon Recent Developments
11.12 B Braun Melsungen
11.12.1 B Braun Melsungen Company Details
11.12.2 B Braun Melsungen Business Overview
11.12.3 B Braun Melsungen Hemostatic Powders and Hemostatic Agents Introduction
11.12.4 B Braun Melsungen Revenue in Hemostatic Powders and Hemostatic Agents Business (2017-2022)
11.12.5 B Braun Melsungen Recent Developments
11.13 Gelita Medical
11.13.1 Gelita Medical Company Details
11.13.2 Gelita Medical Business Overview
11.13.3 Gelita Medical Hemostatic Powders and Hemostatic Agents Introduction
11.13.4 Gelita Medical Revenue in Hemostatic Powders and Hemostatic Agents Business (2017-2022)
11.13.5 Gelita Medical Recent Developments
11.14 Smith & Nephew
11.14.1 Smith & Nephew Company Details
11.14.2 Smith & Nephew Business Overview
11.14.3 Smith & Nephew Hemostatic Powders and Hemostatic Agents Introduction
11.14.4 Smith & Nephew Revenue in Hemostatic Powders and Hemostatic Agents Business (2017-2022)
11.14.5 Smith & Nephew Recent Developments
11.15 Teleflex
11.15.1 Teleflex Company Details
11.15.2 Teleflex Business Overview
11.15.3 Teleflex Hemostatic Powders and Hemostatic Agents Introduction
11.15.4 Teleflex Revenue in Hemostatic Powders and Hemostatic Agents Business (2017-2022)
11.15.5 Teleflex Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer